Changeflow GovPing Trade Procurement PharmaFocus Advisor Tender Notice
Routine Notice Added Final

PharmaFocus Advisor Tender Notice

Favicon for canadabuys.canada.ca CanadaBuys Latest Tenders
Published February 25th, 2026
Detected March 13th, 2026
Email

Summary

The Patented Medicine Prices Review Board (PMPRB) issued a tender notice for a PharmaFocus and Canadian Market Access Advisor. The notice, which closed on March 12, 2026, sought services to collect drug sales data and provide market intelligence.

What changed

The Patented Medicine Prices Review Board (PMPRB) has issued a tender notice (Solicitation number SN25004) for a PharmaFocus and Canadian Market Access Advisor. The PMPRB requires services to collect comprehensive and objective data on drug quantities and revenues sold in Canada by surveying hospitals, pharmacies, and wholesalers. Additionally, the selected advisor will provide publications and subscription services offering updates on pharmaceutical policy changes, public drug plan design, pricing, market developments, and new drug approvals.

This notice, which closed on March 12, 2026, indicates a need for ongoing market intelligence and data collection within the Canadian pharmaceutical sector. While this is a tender notice and not a direct regulatory change for most entities, companies involved in the pharmaceutical market in Canada, particularly those supplying to hospitals, pharmacies, or wholesalers, should be aware of the PMPRB's data collection requirements and market intelligence needs. The contract duration is estimated at 48 months, with a proposed start date of April 1, 2026.

What to do next

  1. Review tender documents for SN25004 if interested in providing advisory services to the PMPRB.
  2. Note the PMPRB's ongoing need for drug sales data and market intelligence.

Source document (simplified)

Buy Canadian Policy

The Government of Canada has introduced new policies to protect, build, and transform Canadian industries. Check out Buy Canadian Policy for more information on what this could mean for you.


PharmaFocus & Canadian Market Access Advisor

Solicitation number SN25004

Publication date

2026/02/25

Closing date and time 2026/03/12 14:00 EDT

Last amendment date

2026/03/12

Status Status
Expired

Description

The PMPRB requires drug information respecting quantities and revenue of medicines sold in Canada. The information must be collected in a complete, objective and non-biased fashion by surveying hospitals, pharmacies and wholesalers across Canada.
The PMPRB also requires publications and associated subscription services that provide regular updates on federal and provincial/territorial policy changes related to pharmaceuticals, public drug plan design and coverage, prices and developments of the Common Drug Review and the recommendations of the Canadian Expert Drug Advisory Committee; as well as information on the latest Notice of Compliance as well as statistics and intelligence on the Canadian pharmaceutical market.

Show more description Show less description

Contract duration

The estimated contract period will be 48 month(s), with a proposed start date of 2026/04/01.

Trade agreements

  • North American Free Trade Agreement (NAFTA)
  • World Trade Organization Agreement on Government Procurement (WTO GPA)
  • Canada-Chile Free Trade Agreement (CCFTA)
  • Canada-Peru Free Trade Agreement (CPFTA)
  • Canada-Colombia Free Trade Agreement
  • Canada-Panama Free Trade Agreement
  • Canada-Honduras Free Trade Agreement
  • Canada-Korea Free Trade Agreement (CKFTA)
  • Canadian Free Trade Agreement (CFTA)
  • Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
  • Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
  • Canada-Ukraine Free Trade Agreement (CUFTA)
  • Canada-UK Trade Continuity Agreement (Canada-UK TCA)

Reason for limited tendering

A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:

  • Exclusive Rights

Partner with another business

Are you interested in partnering with other businesses for this opportunity? Add your company to the list of businesses who are interested in partnering.

This list does not replace or affect the tendering procedures for this procurement process. Businesses are still required to respond to bid solicitations, and to compete based on the set criteria. For more information please read the Terms of use.

Contact information

Contracting organization

Organization Patented Medicine Prices Review Board (PMPRB) Address 333 Laurier Ave West

Ottawa, Ontario, K1P 1C1 Canada Contracting authority Sylvie Beaudoin Phone (343) 575-0363 Email sylvie.beaudoin@pmprb-Cepmb.gc.ca Address 333 Laurier Ave West

Ottawa, Ontario, K1P 1C1 Canada

Bidding details

Full details regarding this tender opportunity are available in the documents below. Click on the document name to download the file. Contact the contracting officer if you have any questions regarding these documents.
| Document title | Amendment no. | Language | Unique downloads | Date added |
| --- | --- | --- | --- | --- |
| SN25004 ACAN ENG.pdf | 001 | EN | 4 | 2026/02/25 |
| SN25004 ACAN FR_0.pdf | 001 | FR | 0 | 2026/02/25 |
Access the Getting started page for details on how to bid, and more.

Related notices

There are currently no notices related to this notice.

Eligibility and terms and conditions

Government of Canada tender and awards notices, solicitation documents, and other attachments are fully accessible and available free of charge and without having to register on CanadaBuys.

Information may be available on another source prior to being available on CanadaBuys. You may have received this information through a third-party distributor. The Government of Canada is not responsible for any tender notices and/or related documents and attachments not accessed directly from CanadaBuys.canada.ca.

Government of Canada tender or award notices carry an OpenGovernment License - Canada that governs its use. Related solicitation documents and/or tender attachments are copyright protected. Please refer to our terms and conditions page for more information.


Summary information

Notice type Advance Contract Award Notice Language(s) English, French Region(s) of delivery National Capital Region (NCR) Region of opportunity Canada Contract duration 48 month(s) Procurement method Advance Contract Award Notice Selection criteria Not applicable Commodity - UNSPSC
Click the links below to see a list of notices associated with the UNSPSC.
-

Support for small and medium businesses

If you have questions about this tender opportunity, please contact the contracting officer, whose information is found in the Contact information tab.

Refer to our Support page if you need help or have questions about the government procurement process, including how to bid or how to register in SAP Ariba. You can also contact Procurement Assistance Canada, which has offices across Canada.

Report a problem on this page Date modified:

2026-03-12

Classification

Agency
Various Canadian Agencies
Published
February 25th, 2026
Compliance deadline
March 12th, 2026 (2 days ago)
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Geographic scope
National (Canada)

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Government Procurement Market Access

Get Trade Procurement alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when CanadaBuys Latest Tenders publishes new changes.

Free. Unsubscribe anytime.